Jessica Anderson Christo

Jessica Anderson Christo has extensive experience in the pharmaceutical and biotech industries. Jessica is currently serving as the Chief Development Operations Officer at IDRx since January 2022. Prior to that, they founded their own consulting company, Jessica Christo Consulting, LLC, in May 2021, where they worked as a Development Consultant.

From 2019 to 2021, Christo held the position of Chief Development Officer at Constellation Pharmaceuticals. Before that, they were the Senior Vice President of Development Operations at Verastem Oncology from July 2017 to November 2018.

Christo also worked at X4 Pharmaceuticals as the Vice President of Clinical Strategy and Operations from December 2015 to June 2017. Prior to that, they held the role of Vice President of Corporate Planning and Operations at Verastem from March 2013 to December 2015.

Jessica'sprevious experience includes roles such as Head of Clinical Operations at Molecular Insight Pharmaceuticals (now Progenics) from May 2012 to March 2013, Senior Director of Clinical Development North America at Fresenius Biotech GmbH (now Neovii) from June 2010 to May 2012, and Executive Director of Program Management & Clinical Operations at TARIS Biomedical (now Johnson & Johnson) from February 2009 to May 2010.

Christo's earlier career includes positions at CombinatoRx, where they served as both Executive Director of Program Leadership from June 2008 to January 2009 and Executive Director of Clinical Operations & Analysis from February 2005 to June 2008.

With their diverse experience in various leadership and development roles, Christo has developed a strong expertise in clinical operations, program management, and corporate planning in the biotech and pharmaceutical industries.

Jessica Anderson Christo has a Master of Arts (M.A.) degree from Texas Tech University. Jessica also holds a Bachelor of Science (B.S.) degree from The University of New Mexico. The specific fields of study for both degrees are not provided.